Douglas Campbell

Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase.

John G Cumming, J. Breed, P. Jewsbury, 2004, Bioorganic & medicinal chemistry letters.

Prevention of MKK6-dependent activation by binding to p38alpha MAP kinase.

Jon Read, Alexander L Breeze, Richard A Norman, 2005, Biochemistry.